The prescription drug Elitek® (rasburicase) is used to help control uric acid levels in people who are undergoing cancer treatment for leukemia, lymphoma, or cancerous solid tumors. It is approved for use in children and adults.
People who are being treated for these specific cancers have an increased risk for developing high uric acid levels. By helping control uric acid levels, Elitek can help prevent potentially dangerous complications, such as kidney failure, seizures, and death. This medicine is given as a slow injection into a vein (an intravenous, or IV, injection) once a day for up to five days.
(Click Elitek Uses for more details on using this drug to manage uric acid levels. This full-length article discusses how this drug works and whether there are any off-label uses.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click